Fig. 1From: Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II studyThe cumulative frequency of selected surgeries in 261 patients with AGel amyloidosis in the FIN-GAR phase II registry. a: Skin or other soft tissue surgeries (n = 170, 65%). b: Cataract surgeries (n = 62, 24%). c: Carpal tunnel syndrome surgeries (n = 68, 26%)Back to article page